# US 2021/0277487 A1 · Detection of colorectal cancer

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0277487 A1
- Document ID: US20210277487A1
- Status: Published application
- Kind: A1
- Application number: 17/329,616
- Filed: 2021-05-25
- Published: 2021-09-09
- Earliest claimed: 2019-05-31
- Assignees: Universal Diagnostics, S.L.
- Applicants: Universal Diagnostics, S.L.
- Inventors: Marko Bitenc; Kristi Kruusmaa; Juan Martinez-Barea; Christian Hense; Marko Chersicola; Primo{hacek over (z)} Knap
- Web page: https://patentgrep.com/patent/US20210277487A1

## CPC

- C12Q 1/6886: for cancer (immunoassay for cancer G01N33/575)
- C12Q 1/686: Polymerase chain reaction [PCR]
- C12Q 2600/112: Disease subtyping, staging or classification
- C12Q 2600/154: Methylation markers
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

## Abstract

The present disclosure provides, among other things, methods for colorectal cancer screening and compositions related thereto. In various embodiments, the present disclosure provides methods for colorectal cancer screening that include analysis of methylation status of one or more methylation biomarkers, and compositions related thereto. In various embodiments, the present disclosure provides methods for colorectal cancer screening that include screening methylation status of one or more methylation biomarkers in cfDNA, e.g., in ctDNA. In various embodiments, the present disclosure provides methods for colorectal cancer screening that include screening methylation status of one or more methylation biomarkers in cfDNA, e.g., in ctDNA, using MSRE-qPCR.

## Claims

### Claim at position 1

-30. (canceled)

### Claim 31

A kit for use in colorectal cancer screening, the kit comprising:
at least one oligonucleotide primer pair for amplification of a methylation locus within a differentially methylated region (DMR) of one or more of the genes according to Table 13.

### Claim 32

(canceled)

### Claim 33 (depends on 31)

The kit of claim 31, wherein the oligonucleotide primer pairs include oligonucleotide primer pairs for amplification of DMRs ZNF471 '558 and FGF14 '577.

### Claim 34 (depends on 31)

The kit of claim 31, wherein the oligonucleotide primer pairs include oligonucleotide primer pairs for amplification of DMRs ZNF471 '558, FGF14 '577, and PDGFD ‘388.

### Claim 35 (depends on 31)

The kit of claim 31, wherein the oligonucleotide primer pairs include oligonucleotide primer pairs for amplification of DMRs ZNF471 '558, FGF14 '577, PDGFD ‘388, ZNF471 '527, and ADAMTS2 '284.

### Claim 36 (depends on 31)

The kit of claim 31, wherein the oligonucleotide primer pairs include oligonucleotide primer pairs for amplification of DMRs ZNF471 '558, FGF14 '577, PDGFD ‘388, ZNF471 '527, ADAMTS2 '284, ADAMTS2 '254, ZNF492 '069, and ST6GALNAC5 '456.

### Claim 37 (depends on 31)

The kit of claim 31, wherein the oligonucleotide primer pairs include oligonucleotide primer pairs for amplification of DMRs ZNF471 '558, FGF14 '577, PDGFD ‘388, ZNF471 '527, ADAMTS2 '284, ADAMTS2 '254, ZNF492 '069, ST6GALNAC5 '456, ZNF542 '502, LONRF2 '281, ZNF132 '415, PDGFD ‘921, ZNF132 '268, CNRIP1 '272, and ALK ‘434.

### Claim at position 9

-41. (canceled)
